BioInsight: Multi-Agent Orchestration for Interactive Biomedical Knowledge Discovery

BioInsight is a multi-agent AI system that transforms static biomedical reports into interactive, evidence-centered interfaces for disease research. The system combines evidence retrieval, mechanistic reasoning, and citation normalization to help researchers inspect findings, assess uncertainty, and refine hypotheses more effectively than traditional text-based outputs.

BioInsight addresses a critical gap in biomedical AI applications: the limitation of static, text-based research reports. While AI-generated analyses have become standard in interpreting protein signals and disease mechanisms, researchers require interactive tools to validate evidence, compare competing hypotheses, and make confident decisions. BioInsight resolves this by orchestrating multiple AI agents to decompose complex tasks—evidence retrieval, mechanistic reasoning, and citation management—into structured, reusable components.

The system's architecture reflects maturity in AI workflow design. By separating evidence gathering from interpretation and using deterministic components for citation normalization, BioInsight ensures reproducibility and traceability—critical for scientific credibility. The conversion of evidence artifacts into interactive dashboards represents a meaningful shift toward human-centered AI, where tools augment rather than replace researcher judgment.

For the biomedical AI industry, this work signals growing demand for interpretability and interactivity in research tools. Academic and pharmaceutical institutions increasingly expect AI systems to provide auditable reasoning chains and visual exploration capabilities. BioInsight's approach of preserving provenance through the entire pipeline—from raw evidence to interactive interface—establishes a template for enterprise biomedical AI solutions.

The evaluation on standardized QA benchmarks and protein-function reasoning demonstrates technical viability, though real-world adoption will depend on integration with existing research workflows and institutional data systems. Organizations developing research intelligence platforms should monitor this approach as evidence that static reports are becoming insufficient for competitive advantage in drug discovery and precision medicine applications.

• →BioInsight moves biomedical AI from static reports to interactive, evidence-centered interfaces for research decision-making.
• →Multi-agent architecture separates evidence retrieval from mechanistic reasoning, improving reproducibility and citation accuracy.
• →The system preserves provenance throughout the pipeline, enabling researchers to inspect and validate reasoning at each step.
• →Interactive dashboards convert the same structured evidence used in reports, reducing redundancy and improving consistency.
• →Results suggest biomedical AI systems should prioritize interactive, provenance-preserving artifacts over text-only outputs.